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Respiratory syncytial virus (RSV) infection is associated with epithelial cell death and vigorous inflammation. In mouse
models, and in immunosuppressed patients, CD81 T cells are necessary for RSV clearance. In vitro, RSV has been shown
to induce expression of several proteins on the respiratory epithelial cell, including RSV proteins, ICAM-1, and MHC class I,
that can potentially interact with CD81 T cells in initiating apoptosis of the target cell. One mechanism of T-cell-directed cell
death is the interaction of FasL on the CD81 T lymphocytes and Fas expressed on the target cell. In order to determine the
ability of RSV to induce Fas on the respiratory epithelium, we studied the RSV infection of a human respiratory epithelial cell
line (A549) in vitro. Fas mRNA and protein levels are increased two-to-fourfold following RSV infection, and transcriptional
upregulation of Fas was demonstrated using promoter/reporter gene constructs. RSV infection directly resulted in cellular
apoptosis, and the frequency of apoptotic cells was further increased by cross-linking with antibodies to Fas. These data
demonstrate that RSV infection induces cellular apoptosis and suggest that interactions of surface Fas with T cells may
further augment this process in vivo. © 1999 Academic PressKey Words: Fas; CD95; respiratory syncytial virus; apoptosis; NF-IL6.
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cRespiratory syncytial virus (RSV) is the major cause of
iral lower respiratory disease in infants. It is the primary
irus isolated from infants with bronchiolitis, the most
ommon reason for hospital admission under 1 year of
ge (Denny and Clyde, Jr., 1986; Anderson and Heilman,
995). RSV infects respiratory epithelial cells and is as-
ociated with a vigorous inflammatory response result-
ng in epithelial cell death and viral clearance in vivo
Aherne et al., 1970; Taylor et al., 1984; Graham et al.,
988). Infection of cell lines and primary epithelial cell
ultures with RSV lead to reproducible patterns of viral
eplication and histopathology ultimately leading to cell
eath (Collins, 1996; Stark et al., 1996; Noah and Becker,
994). Recent studies in vitro using respiratory epithelial
ells (primary cells or immortalized cell lines) have dem-
nstrated that the respiratory epithelium is not just a
assive barrier to viral invasion, but these cells actively
elease several cytokines and chemokines that can po-
entially modulate the nonspecific and immune re-
ponses to RSV infection, including interleukin-6 (IL-6),
1 Current address: Paediatrics, Imperial College of Science, Technol-
gy and Medicine, St. Mary’s Hospital, Norfolk Place, London W2 1PG
K.
2 To whom correspondence and reprint requests should be ad-
ressed at Division of Pulmonary Medicine, Allergy and Clinical Immu-
ology, Children’s Hospital Medical Center, 3333 Burnet Avenue OSB5,
incinnati, Ohio, USA 45229-3039. Fax: (513) 636 4615. E-mail:atarj0@chmcc.org.
042-6822/99 $30.00
opyright © 1999 by Academic Press
ll rights of reproduction in any form reserved.
198L-1, IL-8, granulocyte/macrophage colony-stimulating
actor (GM-CSF), tumor necrosis factor (TNF), and RAN-
ES (Noah and Becker, 1994; Fiedler et al., 1995; Patel et
l., 1995; Becker et al., 1997; Saito et al., 1997). Moreover,
SV infection increases expression of cell receptors rec-
gnized by inflammatory cells, including ICAM-1 and
HC class I proteins (Stark et al., 1996). Therefore, the
espiratory epithelium appears to play a pivotal role in
he inflammatory responses to RSV and limiting its
pread. Indeed, even in immunocompromised hosts RSV
s rarely detected outside the lung, despite prolonged
irus shedding (Cannon et al., 1988).
Cell death can occur among the infected respiratory
pithelial cells by two major mechanisms in eukaryotic
ells: apoptosis and necrosis. Necrosis is a pathologic
orm of cell death that results from acute cellular injury
nd is characterized by rapid cell swelling and lysis
Thompson, 1995). Necrotic cell death could potentially
esult from cell membrane fusion caused by the viral
-protein or other direct viral toxicity. There is substantial
vidence that apoptosis, or programmed cell death, re-
ults from a complex cascade of events possibly initiated
y the activation of specific cellular kinases, leading to
uclear fragmentation (Vaux and Strasser, 1996; Ander-
on, 1997). Apoptosis could be triggered in RSV-infected
ells directly by the virus or through “indirect” pathways
ctivated by inflammatory cell attack of the virus-infected
ells. In vivo, RSV infection is cleared, yet RSV disease is
ugmented by the cellular immune responses to the
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199FAS AND RESPIRATORY VIRUS INFECTIONirus (Cannon et al., 1988; Graham et al., 1991; Alwan et
l., 1992, 1994; Tang and Graham, 1997). The inflamma-
ory cells responding to infection could induce apoptosis
f the RSV-infected epithelium through two separate ap-
ptotic pathways—through degranulation and release of
erforin and granzyme B and through direct cell–cell
nteractions between inflammatory cell Fas-L and Fas
xpressed on the target cell surface, resulting in activa-
ion of families of specific cellular proteases, including
he caspases, that lead to cellular apoptosis (Vaux and
trasser, 1996; Anderson, 1997). Influenza and measles
irus have been demonstrated to induce apoptotic cell
eath (Takizawa et al., 1993; Hinshaw et al., 1994; Esolen
t al., 1995). Moreover, influenza virus was demonstrated
o induce Fas gene expression in cultured Hela cells by
ctivation of the nuclear transcription factor nuclear fac-
or IL-6 (NF-IL6) (consensus sequences for this transcrip-
ion factor have been demonstrated in the Fas promoter)
Wada et al., 1995). RSV also activates NF-IL6 following
nfection of respiratory epithelial cell monolayers, result-
ng in induction of IL-8 synthesis (Jamaluddin et al., 1996;
iedler et al., 1996b).
It was previously demonstrated that RSV infection in-
uces expression of ICAM-1 and MHC class I molecules,
aking the RSV-infected respiratory epithelium a poten-
ial target for cytotoxic CD8 T cells and NK cells (Stark et
l., 1996). In the present studies we report the effect of
SV infection on the expression of Fas by human respi-
atory epithelial cell (A549 cells) cultures. We demon-
trate the upregulation of Fas protein and the induction
as mRNA following RSV infection. Epithelial cell-ex-
FIG. 1. RSV infection increases expression of Fas on respiratory e
V-inactivated RSV (b), or active RSV (c) and Fas expression was me
ntibody and flow cytometry. (A) is a flow cytometry tracing of a repres
reatment with UV-inactivated cells, anti-Fas antibody (b, dark fill), R
sotype-matched control antibody (d, no fill, dotted line). UV inactivation
esults of six separate experiments. Data are shown as median fluo
xperiments (closed circles) and their mean (open circles)] or isotype
open squares)], n 5 6 per group. Error bars represent standard errorressed Fas is biologically functional: cross-linking of pas with monoclonal antibody results in apoptosis of
SV-infected but not control monolayers. Moreover, RSV
nfection alone induced significant levels of cellular ap-
ptosis. These studies have importance in delineating
he potential mechanisms that regulate inflammation,
issue injury, and, potentially, lung repair following RSV
nfection of the airway.
RESULTS
nduction of Fas expression on the cell surface after
nfection after RSV infection
Uninfected A549 cells express low levels of Fas on the
ell surface; however, following RSV infection there is
ignificant increase in Fas levels (Fig. 1A). The upregu-
ation of Fas requires exposure to live virus: A549 cells
xposed to UV-inactivated virus express levels of Fas
imilar to that of mock-infected control cells (represen-
ative histograms, Fig. 1A). Figure 1B summarizes the
esults of six separate experiments, demonstrating the
mall but significant (P , 0.01) increase in Fas protein
ollowing RSV infection (consistently, approximately two-
old higher in RSV-infected cells than in uninfected con-
rols). Fas expression was increased by 6 h following
SV infection and increased only slightly thereafter
24–72 h, Fig. 2).
nduction of Fas mRNA following infection with RSV
Competitive PCR and Northern blot analyses were
sed to detect Fas mRNA in RSV-infected cells. Com-
l cell cultures. A549 monolayers were exposed to media alone (a),
48 h following using FITC-conjugated murine anti-CD95 monoclonal
e experiment showing uninfected cells, anti-Fas antibody (a, gray fill),
ted cells, anti-Fas antibody (c, solid line, no fill), and control cells,
ted Fas upregulation by the RSV preparations. (B) is a summary of the
e for the experimental condition using anti-Fas antibody [individual
l antibodies [individual experiments (closed squares) and their mean
ean; *P , 0.01 compared to uninfected and UV-inactivated controls.pithelia
asured
entativ
SV-infec
preven
rescenc
controetitive PCR was performed using the MIMIC system
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200 O’DONNELL, MILLIGAN, AND STARKprimers indicated under Materials and Methods). The
ajor advantage of the MIMIC method is that the
mplification irrelevant DNA is primed using the same
rimers (and therefore the same annealing conditions)
s used for amplification of Fas. Using 30 cycles of
CR amplification, we consistently demonstrated a
wo- to fivefold increase in Fas following RSV infection
ompared to uninfected controls (data not shown). To
onfirm the PCR data, we performed Northern analysis
or Fas mRNA, using purified, poly-adenylated mRNA.
hen 2–5 mg of poly(A) RNA was loaded onto the gels,
oth the 2.9- and 1.7-kDa Fas mRNA species were
eadily detected in both control and RSV-infected cells
using the 200-bp Fas probe amplified and 32P-labeled
sing PCR, Materials and Methods) (Fig. 3). Fas mRNA
as elevated in the RSV-infected cells compared to
ontrols 24 h following RSV infection and remained
levated through 72 h (an approximately twofold in-
rease by densitometry).
ranscriptional regulation of Fas following RSV
xposure
Because of the relatively small but consistent in-
reases in the levels of both Fas protein and mRNA
ollowing RSV infection of A549 cells, analysis of Fas
romoter activity was performed. For these studies, the
as promoter was cloned into the vector, pGL2-basic,
irecting expression of the firefly luciferase reporter
ene. The luciferase activity was modestly increased in
549 cells transfected with the Fas promoter construct.
FIG. 2. Time course of Fas expression following RSV infection of
549 cells. Fas expression on A549 cells was detected by flow cytom-
try using FITC-labeled specific murine monoclonal antibody to human
as. The data show isotype controls (closed squares) and Fas (CD95)
xpression (closed circles). Fas expression increased significantly by
h and continued to increase through 72 h following RSV. The data are
hown for no infection harvested at 72 h (C) and after infection at 6, 24,
8, and 72 h. The means and standard errors are shown at each time
oint; *P , 0.01 compared to uninfected controls.his activity was further increased (two- to fivefold) fol- cowing infection with RSV (Fig. 4). The analysis of the
ublished sequence of Fas contains several potential
F-IL6 consensus binding sites. Previous reports that
SV infection activated NF-IL6 were confirmed under our
xperimental conditions using electrophoretic mobility
hift assay (EMSA) and supershift assays (data not
hown).
FIG. 3. Northern blot analysis of Fas mRNA from A549 cells following
SV infection. Poly-adenylated RNA was isolated from A549 cells (con-
rol or RSV infected) at intervals following RSV infection and was
nalyzed by Northern blot using a 32P-labeled probe to human Fas.
ane 1 represents an interferon-g-treated Fas-positive control. Lanes 2,
, and 6 contain poly(A) RNA from control cells at 24, 48, and 72 h
ollowing mock infection. Lanes 3, 5, and 7 contain poly(A) RNA from
SV-infected cells at the same time points. Both 2.9- and 1.7-kDa Fas
RNA species are identified. Blots were probed for b-actin as a mRNA
ontrol for equal loading. Fas mRNA was present in greater amounts at
ll three time points compared to control (determined by densitometry).
FIG. 4. Transcriptional upregulation of the Fas gene following RSV
nfection. The 1700 bp 59 proximal to the Fas gene (Fas promoter) was
btained by PCR amplification and cloned into pGL2Basic, directing
xpression of the firefly luciferase gene. The Fas–luciferase construct
as cotransfected into A549 cells, along with a plasmid encoding
-galactosidase (to control for tranfection efficiency). Luciferase activity
as determined 6 h following exposure to RSV and normalized to
-galactosidase. Unfilled bars indicate uninfected and hatched bars
ndicate RSV infected; *P , 0.01 compared to empty vector; †P , 0.01
ompared to uninfected control.
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201FAS AND RESPIRATORY VIRUS INFECTIONSV induces apoptosis in A549 cells—role of Fas
Because of the role of Fas in T-cell-induced apoptosis,
e investigated the biologic activity of this protein using
FIG. 5. RSV infection causes apoptosis in A549 cells, which can be fur
BRDU) DNA strand break labeling, stained using FITC anti-BRDU antibo
lots; (A) is RSV infected 1 anti-Fas, (B) is RSV infected (no antibody), (C)
E) is a summary of data from two separate experiments, n 5 4 per gr
he absence of cross-linking antibody. Error bars represent standard eross-linking monoclonal antibodies. Control cells exhib- gted minimal levels of apoptosis with or without cross-
inking of Fas (Figs. 5C and 5D, respectively). RSV infec-
ion alone increases apoptosis from less than 2% to
hanced with antibody to Fas. Apoptotic cells were detected by Br-dUTP
nd analyzed by flow cytometry. (A–D) are representative flow cytometric
ninfected control 1 anti-Fas, (D) is an uninfected control (no antibody).
, 0.01 compared to control, †P , 0.01 compared to RSV infection in
the mean.ther en
dies, a
is the u
oup: *Preater than 10% of cells (Fig. 5B). Cross-linking Fas on
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202 O’DONNELL, MILLIGAN, AND STARKSV-infected cells with monoclonal antibody further en-
anced apoptosis (Fig. 5A, P , 0.01). The results of four
ndependent assays are summarized for clarity in Fig. 5E.
DISCUSSION
The experiments described here indicate that RSV
nfection increases the expression of CD95 (Fas) on
espiratory epithelial cells. This upregulation was mod-
st in quantity (about twofold) but is consistent in all
easurements of Fas activation used (flow cytometry,
orthern blot, competitive PCR, and promoter analysis)
nd consistent with levels of Fas activation following
nfection with influenza virus reported by Wada et al.
1995). One mechanism for the increased expression of
as appears to be transcriptional upregulation mediated
y RSV-induced activation of the transcription factor NF-
L-6. RSV infection alone caused apoptosis in a human
espiratory epithelial cell line (A549 cells) in culture.
oreover, Fas expressed on the infected cell surface is
iologically functional—apoptosis could be further en-
anced by cross-linking Fas on the infected cell surface,
ncreasing levels of apoptosis in the RSV-infected cell
onolayers.
The Fas upregulation (both transcription and transla-
ion) parallels the increases in RSV mRNA, protein, and
he production of infectious virus particles. The “kinetics”
f RSV replication in A549 cells has been reported pre-
iously (Noah and Becker, 1994; Fiedler et al., 1995).
ollowing exposure of A549 cells to RSV (m.o.i. 5 1),
here is no mRNA for the RSV F protein (measured by
orthern blot) detectable until 16–20 h postexposure.
nfectious virus was present (using plaque assay) after
4 h and peaked by 72 h following infection (Fiedler et al.,
995). Virus replication is accompanied by increases in
as (this report), IL-8 (Fiedler et al., 1995), ICAM-1 (Chini
t al., 1998), and GM-CSF (Noah and Becker, 1994).
ecently published studies demonstrate that type II al-
eolar cells display restricted expression of Fas (Fine et
l., 1997). Fas mRNA was detected from isolates of pri-
ary rat type II and Fas expression on a subset of
lveolar type II cells by in situ hybridization and immu-
ohistochemistry in normal mouse lung (Fine et al.,1997).
ur observations that the A549 cell line can express Fas
s therefore consistent with in vivo observations.
Viral replication is necessary for Fas production: UV-
nactivated RSV fails to upregulate Fas transcription or
ranslation. Similarly, ribavirin treatment of A549 mono-
ayers infected with RSV, or treatment of the cells with
V-inactivated virus, prevents IL-8 production (Fiedler et
l., 1996a). How RSV upregulates expression of these
roteins and the activation of a number of transcription
actors is uncertain. For instance, RSV can increase
CAM-1 expression in respiratory epithelial monolayers
hrough apocrine or paracrine effects of IL-1a induced in
he virus-infected cells (Patel et al., 1995). In these stud- aes, supernatants from virus-infected cells induced
CAM-1 expression, and this expression could be par-
ially blocked by monoclonal antibodies to IL-1a. How-
ver, UV-inactivated virus was unable to induce Fas ex-
ression, implying that virus replication or transcription
f viral proteins is necessary in the process. Clearly,
uch work remains to be done to define the mecha-
isms of viral-induced upregulation of cytokines (IL-8,
M-CSF) and cell surface proteins (Fas, ICAM-1, MHC
lass I), but these data will be key to our understanding
f the regulation of host inflammatory responses to virus
nd viral clearance.
A search of the Fas promoter revealed several possi-
le factors involved in its upregulation by RSV. Several
ites for NF-IL6 have been demonstrated in the 59 prox-
mal DNA sequences of the Fas gene (Wada et al., 1995),
nd we demonstrate activation of NF-IL6 in RSV-infected
549. NF-IL6 induction is required for IL-8 upregulation
ollowing RSV infection (Fiedler et al., 1996b; Mastro-
arde et al., 1996; Jamaluddin et al., 1996) and was
emonstrated by Wada et al. to contribute to Fas upregu-
ation following influenza infection of Hela cells (Wada et
l., 1995), where these investigators also found low-level
nduction of Fas following influenza infection. Inter-
eron-g, a cytokine that induces Fas on many cell types,
as not been found to be produced by A549 cells or
espiratory epithelial cell cultures (unpublished data).
he current studies demonstrate that the upregulation of
F-IL6 is temporally related to Fas upregulation, sug-
esting but not proving the role of NF-IL6 in RSV-induced
as expression. In the present studies, we found that Fas
as expressed at low levels by A549 cells and that RSV
nfection resulted in small but statistically significant
ncreases in biologically active Fas. These small
hanges would be predictable because of the genetic
rganization of the Fas promoter (Wada et al., 1995). The
romoter lacks TATA, GC, and CCAAT sequences, usu-
lly seen in promoters with higher transcription efficien-
ies. Moreover, there are no consensus sites for more
potent” nuclear transcription factors in the Fas promoter
egion, such as NF-kB and AP-1, transcription factors
esponsible for high-level induction of IL-8 and ICAM-1
ollowing RSV infection (Wada et al., 1995; Fiedler et al.,
996b; Mastronarde et al., 1996; Chini et al., 1998).
The Fas detected in the present studies was found to
e biologically functional: cross-linking with monoclonal
ntibodies enhanced virus-induced apoptosis. Fine et al.
ere able to demonstrate Fas on freshly isolated alveo-
ar type II cells and that cross-linking this protein re-
ulted in apoptosis (Fine et al., 1997). Our present data
re consistent with these published data on Fas upregu-
ation and function in cells representative of the distal
irway epithelium. Recently Takeuchi et al. demonstrated
hat RSV infection induced several caspases, including
L-1b converting enzyme (ICE) and its transcriptional
ctivator interferon regulatory factor (IRF-1) (Takeuchi et
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203FAS AND RESPIRATORY VIRUS INFECTIONl., 1998). ICE activation is proinflammatory in that it
esults in converting pro-IL-1b to active cytokine and
ndirectly contributes to an increase in IL-1a (Cohen,
997). Therefore, the activation of ICE following RSV
nfection demonstrated by Takeuchi et al. (1998) is con-
istent with the findings by Patel et al., who demon-
trated that RSV infection increased expression of IL-1a
Patel et al., 1995). Takeuchi also found that expression of
PP32 (caspase-3, one of the key executioner proteins of
poptosis (Cohen, 1997)) was enhanced following infec-
ion of A549 cells with RSV Long strain virus; however,
hey were not able to demonstrate either the apoptosis
r the upregulation of cell surface Fas expression that
e demonstrate in the studies presented here. The dif-
erence in ability to demonstrate apoptosis in the present
tudy and that of Takeuchi may reflect differences in
irus virulence, as found with Sendai virus infection. Itoh
t al. used studied Sendai virus strains with different
irulence (Itoh et al., 1998): a strain of low virulence
reatly enhanced apoptosis and was associated with
ess lung pathology in mice compared to more virulent
trains. Differences in virus virulence, local differences in
he A549 lines, or differences in methodology used to
etermine apoptosis may account for the difference in
irus-induced apoptosis reported by Takeuchi and the
resent report. It is possible that RSV induces cell death
y apoptosis or other pathways under slightly different
xperimental conditions. However, the data reported
ere are consistent with reports of virus-induced apopto-
is by Sendai virus (Itoh et al., 1998), measles (Esolen et
l., 1995), and influenza viruses (Wada et al., 1995) and
emonstate that under the experimental conditions
sed, RSV induces Fas expression and causes cellular
poptosis. The relative importance of each pathway (di-
ect cytopathology and necrosis vs apoptosis) in RSV
nfection is unclear. Apoptosis of the infected cell
through direct effects of virus or through activation of
as by lymphocytes) would potentially provide a host
nimal with a means to limit virus replication while lim-
ting the “collateral damage” in the airway (Collins, 1995).
Apoptosis is a physiologic mechanism of cell death.
ecent studies demonstrate that virus infection and viral
ene products can specifically activate or inhibit apopto-
is from occurring (Collins, 1995). Apoptosis of infected
ells could help to limit the replication of virus and would
herefore be a disadvantage to the infecting virus. In-
eed, several viruses produce products that specifically
revent the apoptotic process, allowing greater viral rep-
ication or viral survival (Collins, 1995). How RSV induced
poptosis in our studies is unknown, but likely involved
nitiation of the apoptotic cascade through mechanisms
ther than direct activation of Fas, since apoptosis was
urther enhanced by cross-linking Fas using monoclonal
ntibodies.
Apoptotic cell death induced through CD95 ligation is
elieved to be mediated by a mechanism consisting of a Feries of cysteine proteases (caspases) that are acti-
ated as a hierarchical cascade, resulting in irreversible
egulated termination of all vital cell processes (Vaux and
trasser, 1996; Barinaga, 1998; Anderson, 1997). Al-
hough a great deal of information is known about CD95-
ediated lymphocyte apoptosis, relatively little is known
bout the role of CD95 in epithelium and the role of
pithelial cells in the induction of specific inflammatory
nd immune responses. Recent studies provide evi-
ence that the respiratory epithelium has the ability to
nitiate or perpetuate lung inflammatory responses to
SV infection. In vitro and in vivo studies demonstrate
hat the RSV-infected respiratory epithelial cells secrete
number of potent proinflammatory molecules, including
ytokines (IL-8, RANTES, GM-CSF), that can contribute to
nflammatory cell recruitment and activation (Noah and
ecker, 1994; Fiedler et al., 1995; Becker et al., 1997). In
ddition, the RSV-infected respiratory epithelial cells ex-
ress increased levels of receptor proteins potentially
ecognized by the immune system, including ICAM-1,
HC class I, and Fas, recognized by migrating inflam-
atory cells, potentially directing and retaining them in
ites of injury. RSV-induced apoptosis alone cannot limit
SV infection in the lung. Irradiated mice can be persis-
ently infected with RSV: this infection can be cleared by
assive transfer of CTL (Cannon et al., 1987). Likewise,
SV infection (pneumonia) is associated with significant
ortality rates in immunocompromised human patients
Hall et al., 1986; Englund et al., 1988; Harrington et al.,
992). Many laboratories have studied the role of T lym-
hocytes in this process and have demonstrated the
entral role of cytotoxic T cells in clearing virus infection
nd in virus-induced lung inflammation (Openshaw,
995; Graham, 1995). CTL-induced killing of virus-in-
ected respiratory epithelial cells is mediated by granular
roteins (perforin and granzyme B) and through FasL
nteractions with Fas on the target cell. Our data dem-
nstrate the presence of all the key components for CD8
cell–infected epithelial cell interactions. We have pre-
iously demonstrated that RSV increases expression of
he RSV glycoproteins ICAM-1 and MHC class I antigen
n the surface of RSV- infected respiratory epithelial cells
Stark et al., 1996), which would allow interactions with
D8 T lymphocyte through the TCR and b2 integrins
Springer, 1995). FasL–Fas interactions could then medi-
te signaling for apoptosis of the infected epithelial tar-
et. The relative importance of these mechanisms in RSV
nfection remains to be determined, but clearly, the ability
o regulate the extent of these inflammatory responses is
ey to understanding and treating the immunopathology
f RSV lower respiratory disease.
In summary, we show for the first time that RSV in-
uces apoptosis and Fas expression in the A549 pneu-
ocyte cell line. Fas expression is enhanced and allows
ctivation of the apoptotic cascade by cross-linking anti-
as antibody. These effects are temporally associated
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204 O’DONNELL, MILLIGAN, AND STARKith activation of the transcription factor NF-IL6. Apopto-
is may play a role in modulating airway inflammation
aused by RSV and eliminating virus from the lung.
MATERIALS AND METHODS
eagents
Tissue culture media and reagents, including incom-
lete Hanks’ balanced salt solution (iHBSS), Eagle’s min-
mal essential medium (MEM), trypsin (0.5%), and fetal
alf serum (FCS) were obtained from GIBCO BRL (Grand
sland, NY). Plasticware (pipettes, flasks, tissue culture
ishes, Falcon) were obtained from Fisher Scientific.
uman respiratory epithelial cell (REC) culture
Due to its low baseline expression of ICAM-1, A549, an
mmortalized human alveolar type 2 epithelial cell line
ATCC, Rockville, MD), was selected as a source of REC
or these studies (Lieber et al., 1976). A549 cells were
aintained in MEM supplemented with 8% FCS in ven-
ilated 150-cm2 sterile tissue culture flasks (Corning,
orning, NY). When confluent, the cells were treated with
rypsin–EDTA and passed into sterile 24-well tissue cul-
ure plates (Falcon) at a density of 50,000 cells/cm2. The
549 cultures used for these studies were limited to
assage numbers 82–95. Cell lines and virus were
ested for mycoplasma prior to the studies described.
ropagation of virus, UV inactivation, and infection of
549 cultures
Respiratory syncytial virus (RSV A2) (ATCC) was prop-
gated in near confluent monolayers of Vero cells (Afri-
an green monkey kidney, ATCC) grown in sterile tissue
ulture plates (20 3 100 mm) as described previously
Fiedler et al., 1996b). An aliquot of the virus preparation
as titrated by plaque assay on CV1 (African green
onkey kidney, ATCC) cells grown in 24-well tissue
lates.
UV inactivation of an aliquot of RSV stock virus was
erformed by transillumination of the RSV preparation in
sterile cell culture dish for 20 min, as previously de-
cribed (Fiedler et al., 1995). Infecting susceptible CV1
ells with a volume of UV-irradiated virus preparation
hat should have contained 107 PFU of RSV resulted in no
etectable infectious virus, confirming that the virus had
een rendered nonreplicative. “Infections” with the UV-
reated RSV were done in parallel with a nonirradiated
liquot of virus, and the volume of UV-inactivated virus
sed for “infection” was based on the volume of non-
reated preparation needed to give the desired multiplic-
ty of infection.
low cytometric analysis
Flow cytometry was used to identify Fas (CD95) on
ontrol and RSV-infected A549 cells. Near confluent Conolayers were exposed to RSV at an estimated m.o.i.
1, and the infected cells (and uninfected controls) were
ncubated at 37°C until harvested for study. Cells were
emoved from the culture dishes using 10 mM EDTA as
escribed previously (Stark et al., 1996), fixed using 2%
ormaldehyde in hypertonic PBS for 20 min, and resus-
ended in PBS containing 1% BSA and 0.1% sodium azide
PBS/BSA/azide). The A549 cells (5 3 105) were stained
or 20 min with either FITC-conjugated anti-human CD95
mouse IgG1 isotype, Pharmingen, San Diego, CA) or
sotype-matched FITC-conjugated control at 12.5 mg/ml.
low cytometric data were acquired using a FACScan
low Cytometer (Becton–Dickinson, San Jose, CA) and
nalyzed using CELLQuest software (Becton–Dickinson).
NA isolation and Northern blot analysis
Fas mRNA production following RSV infection was
nalyzed by Northern blot using standard procedures,
odified as described previously (Chomoczynski and
acchi, 1987; Sambrook et al., 1989; Fiedler et al., 1996b;
hini et al., 1998) using the Qiagen RNeasy kit following
he manufacturer’s protocols (Qiagen, Chatsworth, CA). It
as necessary to prepare poly(A) RNA using the PolyAT-
ract mRNA Isolation System, following the manufactur-
r’s directions (Promega, Madison, WI). For Northern blot
nalysis of these samples, 2 mg of poly(A) RNA was
eparated by electrophoresis in glyoxal–agarose gels
nd transferred to a nylon membrane (Hybond N, Amer-
ham Life Science, Arlington Heights, IL). The blots were
robed with labeled cDNAs corresponding to Fas
200-bp PCR product, below) or b-actin labeled with 32P,
sing a random primer labeling kit (Gibco/BRL, Gaithers-
urg, MD). Blots were stripped between hybridizations
ith each probe in 0.013 SSPE/0.1% sodium dodecyl
ulfate (SDS) at 95°C for 30 min (Sambrook et al., 1989).
loning of the Fas gene
The Fas gene was cloned by PCR using oligonucleo-
ides determined by the published sequence. (Fas 59
rimer: 59-ATG CTG GGC ATC TGG ACC CTC-39; Fas 39
rimer: 59-CTA GAC CAA GGT TTG GAT TTC-39). The
CR product was purified from low melting point agarose
Gibco/BRL) using the Elutip method (Schleicher &
chuell Inc., Keene, NH). This PCR fragment (1 kb) was
hen cloned into the pGEM-T vector using the manufac-
urer’s directions (Promega, Madison, WI), and appropri-
te constructs were identified by restriction endonucle-
se analysis and by PCR using nested internal primers.
he Fas gene products were subcloned into the Blue-
cript(KS) (Strategene, La Jolla, CA) vector using the PstI
nd ApaI sites. The identity of the cloned PCR product
as confirmed by two methods: PCR analysis using a
ested set of PCR primers (59 internal primer: ATG CTG
GC ATC TGG ACC CTC-39; 39 internal primer: AGC TTT
CT TTC ACC TGG AGG-39) and DNA sequence analysis
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205FAS AND RESPIRATORY VIRUS INFECTIONf 100 bases at each end of the putative gene product
confirming sequence and orientation, comparing the
roduct to published Fas sequence (Itoh et al., 1991;
ada et al., 1995)).
loning of the 59-flanking region of the Fas gene (the
as promoter)
The Fas promoter was cloned by PCR amplification
sing human genomic DNA as the template. Primers
ere synthesized using published sequence by the Uni-
ersity of Cincinnati DNA Core Facility (59 primer con-
aining a BglII site: 59-GTG GAA GAT CTG GTT GTT GAG
AA TCC TCC GAA GTG-39; 39 primer containing a BglII
ite: 59-CCC GGG GTA CCA AGC TTT TTT GGC TAC ATT
TT TTA-39). PCR was performed at a 60° annealing
emperature, and the reaction optimized by supplement-
ng with 5% DMSO and 10 mM MgCl2. The expected PCR
roduct (approximately 1.7 kb) was purified using elec-
rophoresis through low melting point agarose and elu-
ion as described above and cloned into pBlueScript(KS)
t the EcoRV site after adding unpaired T’s. For the
xpression experiments, this promoter construct was
ubcloned into pGL2-basic (Promega) using the BglII
nd KpnI restriction sites added by PCR. The resulting
roduct and its orientation were confirmed by limited
NA sequence analysis (200 bp from each end).
ompetitive PCR studies
Because of the low abundance of Fas mRNA in the
549 cultures, competitive PCR studies were performed
o quantify Fas message following infection with RSV.
he competitive PCR experiments were performed using
he Clontech MIMIC Construction Kit according to the
anufacturer’s instructions (Clontech Laboratories Inc.,
alo Alto CA). The PCR primers for the neutral MIMIC
DNA were constructed to contain the Fas PCR primers
t its ends, yielding a fragment of approximately 400 bp
59 primer: 59-ATG CTG GGC ATC TCC ACC CTC CGC
AG TGA AAT CTC CTC CG-39; 39 primer: 59-AGC TTT
CT TTC ACC TGG AGG TCT GTC AAT GCA GTT TGT
G-39). PCR products were separated using electro-
horesis in 1–2% agarose and identified by staining with
thidium bromide. The resulting DNA bands were quan-
ified using a phosphorimager, comparing intensities
ith the MIMIC competitive products, as described by
he manufacturer.
as promoter activation/transfection experiments
In order to test the hypothesis that RSV upregulation of
as gene expression occurs at the transcriptional level,
e utilized the reporter construct described above. A549
ells were transfected with the reporter construct and
CMV/pCMV/b-galactosidase as described previously
Chini et al., 1998; Fiedler et al., 1996b). Following trans-
ection, A549 cells were incubated overnight prior to anfection with RSV. Infections were performed as de-
cribed above, and samples were obtained at intervals
or measurement of luciferase and b-galactosidase ac-
ivity as described previously (Chini et al., 1998; Fiedler et
l., 1996b).
reparation of nuclear extracts and EMSA for NF-IL6
Nuclear extracts were prepared as described previ-
usly (Fiedler et al., 1996b). The nuclear extracts were
liquotted and stored at 270°C until assay. EMSA were
erformed using the nuclear extracts, and 32P-labeled
ouble-stranded oligonucleotides containing the NF-IL6
onsensus sequence (CAG TTG GCA AAT CGT, prepared
y the Oligonucleotide Core Facility at the University of
incinnati) (Akira et al., 1990). Equivalent amounts of
rotein (milligram basis) were incubated with the labeled
robe (100,000 dpm) for EMSA studies. For antibody
upershift assays, 1 mg of rabbit polyclonal antibody to
F-IL6 (Santa Cruz Biotechnology, Santa Cruz, CA) was
ncubated on ice for an additional 60 min. Bound and free
robes were resolved using nondenaturing polyacryl-
mide gel electrophoresis (Fiedler et al., 1996b).
ross-linking Fas with anti-CD95 monoclonal antibody
In order to assess the biologic function of the Fas
etected on the A549 cell surface, cross-linking studies
ere performed using antibody to CD95. Anti-CD95
azide free, clone DX2 mouse isotype IgG1 (Pharmingen)
nd Protein G (recombinant from Streptococcus sp.,
igma Chemical Co. St. Louis, MO) were present in the
549 cultures from the time of RSV infection until har-
esting (72 h), at concentrations of 5 and 2 mg/ml, re-
pectively.
poptosis studies
A549 cells were analyzed for apoptosis using the Apo-
RDU kit (Pharmingen) and flow cytometry. Cells were
arvested for apoptosis studies by gentle treatment with
rypsin. Supernatants from each well were saved so that
etached cells would be included in the analysis. Acri-
ine orange staining was performed at 5 mg/ml for 15
in and cells were visualized by ultraviolet microscopy.
urther cell aliquots were fixed with 1% paraformaldhyde
or 15 min and then 70% ethanol at 220°C overnight.
ells were then washed and labeled with BRDU before
taining with FITC-conjugated antiBRDU and treatment
ith propidium iodide and RNase (ApoBRDU kit, Phar-
ingen). Cells were then analyzed by flow cytometry.
ata were collected by gating on propidium iodide and
xpressed as percentage FITC positive by comparison
ith known controls.
tatistical analysis
Data are expressed 6 standard deviation. Statistical
nalysis of the data included an overall ANOVA followed
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206 O’DONNELL, MILLIGAN, AND STARKy paired Student’s t tests, using the statistical functions
n the Quattro Pro spreadsheet program (Corel Corp.,
armingdale, NY). A probability of P , 0.05 was consid-
red significant. Bonferroni adjustments were used to
orrect for multiple comparisons.
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